Exploring Psychedelics for Pain and Depression

This chapter examines the academic backgrounds of speakers discussing the therapeutic potential of psychedelics in treating chronic pain and depression. It highlights the transition from population-level research to clinical trials, focusing on substances such as psilocybin, LSD, and mescaline. The discussion includes the mechanisms of these psychedelics, their effects on mood and pain perception, and the complexities involved in conducting clinical trials for these innovative treatments.